Effects of Augmented Reality Motor Training on Gait and Balance in Children with Cerebral Palsy: Randomized Controlled Trial
Abstract
Highlights What are the main findings? Adding four weeks of augmented reality motor training (ARMT) to conventional rehabilitation was associated with selective between-group differences in gait parameters, including bilateral stride cycle duration, right double-support variability, and propulsion index. However, no additional effects of ARMT were observed on overall balance, walking speed, stride length, gait quality, or gait symmetry. What are the implications of the main findings? The short-term ARMT did not demonstrate comprehensive additional benefits over conventional rehabilitation in children with spastic cerebral palsy. The observed effects of ARMT on specific gait parameters should be considered exploratory results that require next confirmation in larger trials with pre-specified primary outcomes. Abstract Background: The current evidence regarding the impact of augmented reality (AR) rehabilitation on motor function in children with cerebral palsy (CP) remains limited. Objectives: This study aimed to evaluate whether integrating AR motor training (ARMT) into conventional rehabilitation enhances gait and balance outcomes compared to conventional rehabilitation alone. Methods: Forty children aged 7 to 12 years with unilateral or bilateral spastic CP were randomly assigned to receive either ARMT integrated into a 4-week conventional rehabilitation program (n = 20) or conventional rehabilitation alone (n = 20). The ARMT replaced 20–30 min of standard motor therapy…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 35 participants or records.
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.